The FDA has updated its alert regarding Boston Scientific’s call for providers to check the connections of their patients’ implanted defibrillators, where calcification growth over time c | Boston ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/jzdsqz/global_and) has announced the addition of the "Global and Chinese ...

The FDA issued a correction related to a recall of Boston Scientific (NYSE:BSX) defibrillation leads, labeling it the most serious kind.

Alex Gonzaga revealed that she had her nose implant removed last July, a decision she made after struggling with redness and irritation on her nose for quite some time. Gonzaga opened up about having ...

The U.S. holds 4.7% of the PTFE market in 2025, driven by aerospace, pharma, semiconductors, and specialty grades for medical ...

The FDA has issued an alert regarding a safety concern with certain Boston Scientific defibrillator leads used in implantable cardioverter defibrillators. The affected models include Endotak Reliance, ...